Follow-the-crowd investing can be a risky strategy. It’s the people who identify “what’s coming next” and get in early who make the real money.

By the time the crowd gets involved, gains are often few and far between.

One could argue that this process is playing out again in the MMJ market. At a time when “the crowd” is busy searching for that next hot MMJ stock that may never actually reach the high expectations placed upon it …

Smart investors have already moved on to the next big thing. And what is that next big thing?

They’re betting on psychedelics!

In fact, psychedelic-assisted psychotherapies are now being called “the mental MMJ” of the future.

Many believe that psychedelics could quickly become an in-demand treatment for traumatic brain injury, depression, anxiety, PTSD, addiction, and more.

Look what has already happened in this marketplace:

  • Compass Pathways, which received FDA Breakthrough Therapy designation for its psilocybin therapy program in treatment-resistant depression in 2018, saw its value surge to US$5 million on December 16, 2021.
  • MindMed, which is currently conducting Phase 2A clinical trials evaluating the efficacy of treating anxiety with LSD, saw its value reach US$694 million on that same date.

But these developments are likely just the warning tremors for a much larger earthquake to come. By that we mean, this market could be primed for rapid growth and multiple breakouts.

So, Could ‘Mushrooms’ Really Cause The Next Magical Market Growth Spurt?

In a word – “yes!” Clearly, as the above developments show, investors are already willing to pump cash into promising psychedelic companies.

We believe that is particularly good news for one specific company – Numinus Wellness (TSX:NUMITSX:NUMI).

Numinus Wellness was the first publicly traded company in Canada to be granted a license by Health Canada to grow and research the standardization of psilocybin from mushrooms.

Its current market capitalization, strong scientific background, and state-of-the-art lab facility appear to make it seriously undervalued compared to its industry peers.

In other words, it could be poised for massive growth as this market continues to expand and mature.

Also working in its favor is the company’s unique two-pronged business approach.

Numinus Bioscience

Numinus Wellness (TSX:NUMITSX:NUMI) is the first public company to complete a legal harvest of psilocybe mushrooms and is among the first public companies licensed to handle a variety of different psychedelic substances including Special K, Acid, DMT, molly, psilocin, and psilocybin.

Numinus Health

Numinus now has five wellness clinics across Canada with a total of 21 treatment rooms and two dedicated research clinics where psychedelic studies are being conducted. The company also completed the acquisition of the Neurology Centre of Toronto, which will be built into a comprehensive neurologic care center specialized in psychedelic neurology.

Now if we stopped right here this would already be a company to watch in the coming weeks and months. But there is more to the Numinus Wellness story…

This is a psychedelics business with very strong financials as well!

For instance, Numinus Wellness (TSX:NUMITSX:NUMI) went public last year, after raising an initial $10M with institutional support from Canaccord Genuity and Eight Capital. The company then closed an oversubscribed financing for an additional $17M and a $40M bought deal financing in March 2021.1

And it’s only been uphill from there. Numinus just reported outstanding Q4 and FY 2021 results that included:

  • A strong year-end cash position of $59.2 million
  • Revenues that grew 81% year-over-year to $0.5 million for Q4 2021
  • Revenues that grew 72% year-over-year to $1.5 million for FY 2021

Then on December 16, Numinus Wellness (TSX:NUMITSX:NUMI) graduated to the Toronto Stock Exchange.

Combine the two revenue streams with a very strong financial position and positive recent developments like the move to the TSX and it starts to become very clear why we’re so excited about this company!

But if that is still not enough to peak your interest …

Here are 6 more reasons we believe you should start doing your due diligence on Numinus Wellness (TSX:NUMITSX:NUMI) and the psychedelics market right away.

6 Attention-Grabbing Additional Reasons to Learn More About Numinus Wellness (TSX:NUMITSX:NUMI):

  1. Prolific Investors Entering the Market – Peter Thiel, the founder of PayPal and Palantir, has been investing in psychedelics, along with Kevin O’Leary and Bruce Linton.
  2. Regulatory Changes Happening Fast – Just like what happened with cannabis, psychedelics are gaining momentum as the regulatory policies begin to adapt to the evolving landscape.
  3. Health Canada-Licensed Lab – It’s the first public company with a license to cultivate and harvest psilocybin for research and development. Future products are planned.
  4. Huge Potential Upside – Numinus has a low market capitalization relative to the total addressable market value (which is $100 billion), valued at US$79.9 million on December 22, 2021 and a strong year-end cash position of $59.2 million
  5. Seasoned Management & R&D Team – The company has a medical team with over 500+ peer reviewed publications and a management team with a strong capital markets IQ.
  6. Upcoming Clinical Trials – Two clinical trials about to launch: Phase 1 study for proprietary psilocybe extract and Phase 3 open label extension study partnership with MAPS for molly for PTSD2

So don’t wait for the crowd to find out – by then it may be too late with big gains already being achieved!

The recent global lockdown brought increased attention to mental health and substance abuse, which isn’t likely to go away once the health crisis ends.

The truth is that mental illness has reached crisis proportions and psychedelics are emerging as a new category of medicine that show tremendous promise in treating mental illness.

Click here now to learn much more – including why we believe Numinus Wellness (TSX:NUMITSX:NUMI) is uniquely positioned to take a lead role in mental health treatment going forward.

 

Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.

2)The Article was issued on behalf of and sponsored by, Numinus Wellness Inc. Market Jar Media Inc. has or expects to receive from Numinus Wellness Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) ninety-two thousand, nine hundred and fifty-six American dollars for 141 days (96 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Microsmallcap.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Microsmallcap.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.

6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management’s expectations regarding Numinus Wellness Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Numinus Wellness Inc.’s industry; (b) market opportunity; (c) Numinus Wellness Inc.’s business plans and strategies; (d) services that Numinus Wellness Inc. intends to offer; (e) Numinus Wellness Inc.’s milestone projections and targets; (f) Numinus Wellness Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Numinus Wellness Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Numinus Wellness Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Numinus Wellness Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Numinus Wellness Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Numinus Wellness Inc.’s ability to enter into contractual arrangements with additional Pharmacies; (e) the accuracy of budgeted costs and expenditures; (f) Numinus Wellness Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Numinus Wellness Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Numinus Wellness Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Numinus Wellness Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Numinus Wellness Inc.’s business operations (e) Numinus Wellness Inc. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, Numinus Wellness Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Numinus Wellness Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Numinus Wellness Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document.

7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Numinus Wellness Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Numinus Wellness Inc. or such entities and are not necessarily indicative of future performance of Numinus Wellness Inc. or such entities.

IMPORTANT NOTICE AND DISCLAIMER

This website is owned and hosted by Market Tactic Media Ltd. Articles appearing on this website should be considered paid advertisements. Market Tactic Media Ltd. and its owners, managers, employees, and assigns (collectively “the Website Host”) is often paid by marketing companies to host websites on which articles profiling public companies are published. The Website Host has not been compensated by any of the profiled companies. The Website Host’s compensation for articles appearing on this website is as follows:

  • The Website Host has been paid approximately $500 per week while the advertisement campaign is active by Think Ink Marketing as compensation to host the article profiling Numinus Wellness Inc.

SHARE OWNERSHIP

The Website Host does not own any shares of any profiled Numinus Wellness Inc. and has no information concerning share ownership by others of any profiled Numinus Wellness Inc. The Website Host cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases.

NO SECURITIES OFFERED

The articles on this website are not, and should not be construed to be, offers to sell or solicitations of an offer to buy any security. Neither the articles on this website nor the Website Host purport to provide a complete analysis of any Numinus Wellness Inc. or its financial position. The Website Host is not, and does not purport to be, a broker-dealer or registered investment adviser. The articles on this website are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the Numinus Wellness Inc. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled Numinus Wellness Inc.’s SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.

INDEMNIFICATION/RELEASE OF LIABILITY

By reading articles on this website, you acknowledge that you have read and understood this disclaimer, and further that to the greatest extent permitted under law, you release the Website Host, its affiliates, assigns and successors from any and all liability, damages, and injury from articles appearing on this website. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

LINKS TO THIRD PARTY WEBSITES

This website enables users to link to external websites not under the control of The Website Host. The Website Host has no control over the nature, content, and availability of those sites. The inclusion of any links is not intended as, and should not be construed as, a recommendation or endorsement of the content or views expressed on such external websites. The Website Host expressly disclaims any representation concerning the quality, safety, suitability, or reliability of any external websites and the content and materials contained in them. It is important for users to take necessary precautions, especially to ensure appropriate safety.

INTELLECTUAL PROPERTY

The Market Tactic is the Website Host’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Website Host is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Website Host to any rights in any third-party trademarks.

FORWARD LOOKING INFORMATION

This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect expectations regarding Numinus Wellness Inc. future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Numinus Wellness Inc. industry; (b) market opportunity; (c) Numinus Wellness Inc. business plans and strategies; (d) services that Numinus Wellness Inc. intends to offer; (e) Numinus Wellness Inc. milestone projections and targets; (f) Numinus Wellness Inc. expectations regarding receipt of approval for regulatory applications; (g) Numinus Wellness Inc. intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Numinus Wellness Inc. expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Numinus Wellness Inc. business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Numinus Wellness Inc. ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Numinus Wellness Inc. ability to enter into contractual arrangements; (e) the accuracy of budgeted costs and expenditures; (f) Numinus Wellness Inc. ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption as a result of COVID-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Numinus Wellness Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Numinus Wellness Inc. operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as the COVID-19 pandemic may adversely impact Numinus Wellness Inc. business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Numinus Wellness Inc. business operations (e) Numinus Wellness Inc. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, the Website Host undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise.

HISTORICAL INFORMATION

Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Numinus Wellness Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Numinus Wellness Inc. or such entities and are not necessarily indicative of future performance of Numinus Wellness Inc. or such entities.